NCT05656105View on ClinicalTrials.gov

Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients with Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) Infection

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 10, 2023

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
SARS CoV-2 Post-Acute Sequelae
Interventions
DRUG

DPA-714 PET/MRI

DPA-714 PET/MRI

Trial Locations (1)

35249

RECRUITING

UAB, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER